Increased Density of Renal Amylin Binding Sites in Experimental Hypertension

Hypertension

Volumn 30, Issue 3, 1997, Pages 455-460

  Wookey, Peter J ^a   Cao, Zemin ^a   van Geenen, Rutger C I ^a   Voskuil, Michiel ^a   Darby, Ian A ^a   Komers, Radko ^a   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; IODINE 125;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; HYPERTENSION; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030863656     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.455     Document Type: Article

References (36)

1. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM. Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A. 1987;84:8628-8632.
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KD. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A. 1987;84:3811-3815.
3. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, Westermark P. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein-A gold techniques. Am J Pathol. 1988;130:1-8.
4. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky JGJ, Porte JD. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 1990;39:634-638.
5. Wookey PJ, Tikellis C, Du H-C, Qin H-F, Sexton PM, Cooper ME. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase and activation of plasma renin. Am J Physiol. 1996;270:F289-F294.
6. Harris PJ, Cooper ME, Hiranyachattada S, Berka JL, Kelly DJ, Nobes M, Wookey PJ. Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. Am J Physiol. 1997;272:F13-F21.
7. Cooper ME, Wookey PJ. Amylin: its role in the kidney. Nephrol Dial Transplant. 1997;12:8-10.
8. Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994;15:163-201.
9. Deems RO, Deacon RW, Young DA. Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem Biophys Res Commun. 1991;174:716-720.
10. Young AA, Gedulin B, Gaeta LS, Prickett KS, Beaumont K, Larson E, Rink TJ. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat: evidence for a metabolic role of endogenous amylin. FEBS Lett. 1994;343:237-241.
11. MacIntyre I. Amylin-amide, bone conservation and pancreatic beta cells. Lancet. 1989;2:1026-1027.
12. Cornish J, Callon KE, Cooper GJ, Reid IR. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun. 1995;207:133-139.
13. Cooper ME, McNally PG, Phillips PA, Johnston CI. Amylin stimulates plasma renin concentration in humans. Hypertension. 1995;26:460-464.
14. Young AA, Nuttall A, Moyses C, Percy A, Vine W, Rink T. Amylin stimulates the renin-angiotensin-aldosterone axis in rats and man. Diabetologia. 1995;38(suppl 1):A225. Abstract.
15. Williams B. Insulin resistance: the shape of things to come. Lancet. 1994;344:521-524.
16. Young AA, Rink TJ, Vine W. Gedulin B. Amylin and syndrome X. Drug Dev Res. 1994;32:90-99.
17. Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME. Renin expression in renal ablation. Hypertension. 1992;20:483-490.
18. Miskell CA, Simpson DP. Hyperplasia precedes increased glomerular filtration rate in rat remnant kidney. Kidney Int. 1990;37:758-766.
19. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 1973;34:279-282.
20. Darby IA, Evans BA, Fu P, Lin GB, Moritz KM, Wintour EM. Erythropoietin gene expression in fetal and adult sheep kidney. Br J Haematol. 1995;89:266-270.
21. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Burst Singer K, Nast C, Cohen AH, Ormos J, Silva FG. Human acute tubular necrosis: a lectin and immunohistochemical study. Hum Pathol. 1995;26:230-239.
22. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta 2-adrenergic receptor: extending the ternary complex model. J Biol Chem. 1993;268:4625-4636.
23. Gotze K, Jakobs KH. Unoccupied beta-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes. Eur J Pharmacol. 1994;268:151-158.
24. Arendshorst WJ, Beierwaltes WH. Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol. 1979;237:F38-F47.
25. Arendshorst WJ, Beierwaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol. 1979;236:F246-F251.
26. Larson TS, Lockhart JC. Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine. Am J Physiol. 1995;268:F907-F912.
27. Kato T, Kassab S, Wilkins FC, Kirchner KA, Keiser J, Granger JP. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension. 1995;25[pt 2]:883-887.
28. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in the renal resistance arteries of hypertensive rats. Hypertension. 1996;28:59-63.
29. Kleinknecht C, Terzi F, Burtin M, Laouari D, Maniar S. Experimental models of nephron reduction: some answers, many questions. Kidney Int. 1995;47:S51-S54.
30. De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem. 1980;255:7108-7117.
31. Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol. 1992;41:549-560.
32. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995;268:1350-1353.
33. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Finding JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
34. Diez J, Alonso A, Garciandia A, Lopez R, Gomez-Alamillo C, Arrazola A, Fortuno A. Association of increased erythrocyte Na+/H+ exchanger with renal Na + retention in patients with essential hypertension. Am J Hypertens. 1995;8:124-132.
35. Laragh JH, Letcher RL, Pickering TG. Renin profiling for diagnosis and treatment of hypertension. JAMA. 1979;241:151-156.
36. Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhausl W, Prager R. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia. 1994;37:188-194.